This clinical trial studies whether Acceptance and Commitment Therapy for patients with hepatobiliary cancers (ACT-HBC) can be used to help improve cancer distress. Patients with hepatobiliary cancer (HBC) often experience high levels of distress and reductions in quality of life. ACT-HBC is a behavioral intervention tailored to patients with HBC. It helps patients cope with difficult thoughts and emotions while staying connected to what matters most in life, which may be an effective way to improve cancer distress.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
60
Attend ACT-HBC telehealth group sessions
Ancillary studies
Attend ACT-HBC telehealth group sessions
Mayo Clinic in Rochester
Rochester, Minnesota, United States
RECRUITINGPatient satisfaction
The Institute for Healthcare Improvement 10-point Likert scale (0-10) asks: "Would you recommend this program to your friends and family?" A score ≥ 7 indicates high individual satisfaction. Program satisfaction is achieved if 50% of individuals meet this cut-off.
Time frame: At 8 weeks
Patient session attendance (Feasibility)
Feasibility will be determined by the number of patients attending ≥ 4 sessions.
Time frame: At 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.